Meeting
2020 ASCO Virtual Scientific Program
Gender-based disparities in clinical trials supporting FDA approval of oncology drugs.
Authors
Marjorie Zettler
Cardinal Health, Dublin, OH
Marjorie Zettler , Bruce A. Feinberg , Jonathan Kish , Ajeet Gajra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Research Design
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2058)
DOI
10.1200/JCO.2020.38.15_suppl.2058
Abstract #
2058
Poster Bd #
50
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Gender disparity in authorship of clinical trials leading to cancer drug approvals between 2008 and 2018: The glass ceiling of academic oncology.
First Author: Lynne O. Chapman
Poster
2023 ASCO Breakthrough
Disparities in African-American patient enrollment in pivotal phase 3 immunotherapy trials that led to FDA drug approval in patients with non-small cell lung cancer.
First Author: Chimezie Ubbaonu
Poster
2023 ASCO Annual Meeting
The inclusion of health-related quality of life and other patient-reported outcomes in landmark trials for Food and Drug Administration oncology drug approvals: An analysis of cancer drug approvals between 2006 and 2022.
First Author: Ademola Samuel Ojo
Poster
2023 ASCO Annual Meeting
Geographical and baseline clinical characteristics of participants enrolled in hepatocellular carcinoma (HCC) trials: Analysis of US FDA approvals.
First Author: M. Naomi Horiba